Objective: Hospitalizations for acute asthma are thought to be highly preventable through
the use of efficacious medications, though many patients have poor metered-dose inhaler …

Background Generally, a short-acting beta-2 agonist (SABA) delivered via metered-dose
inhaler (MDI) is recommended for quick relief of asthma symptoms. However, in the PeRson …

Background Short-acting β2-agonist (SABA) nebulization is commonly prescribed for
children hospitalized with severe asthma exacerbation. Either intermittent or continuous …

OBJECTIVES: Asthma exacerbations are a leading cause of hospitalization among children.
Despite the existence of hospital protocols and national guidelines, little guidance is …

Introduction: Although pediatric asthma continues to be a highly studied disease, data to
suggest clear strategies to decrease asthma related revisits or readmissions is lacking. The …

Methods Adults and children (n= 299) who reported a physician-diagnosis of asthma and a
current prescription for short-acting beta agonist (SABA) were enrolled in a pre-post pilot …

Background Despite little evidence for its effectiveness, the breath-actuated nebulizer (BAN)
is the default albuterol delivery method in our pediatric emergency department. Objective …

Objective To determine the effectiveness of a home-based asthma education intervention in
increasing appropriate nebulizer use and reducing symptom frequency, emergency …

In the emergency room, MDIs with holding chambers are as effective as nebulizers for
delivering beta2 agonists to treat acute asthma in adults and children older than age two …

Objective To compare the effectiveness of the administration of inhaled beta‐agonists
delivered via a metered‐dose inhaler (MDI) with spacers—as part of an evidence‐based …